Breaking News

Cytovance Biologics Celebrates 20 Years in Oklahoma City

Over the past 20 years, the company has grown from a small startup into a trusted CDMO partner for biopharma companies worldwide.

Author Image

By: Charlie Sternberg

Associate Editor

(L to R) Dennis Pruitt, Senior VP of Economic Development at Greater Oklahoma City Chamber, Dr. William Canfield, Co-Founder of Cytovance Biologics, Deborah Moorad, Secretary of Commerce for the State of Oklahoma, Ping Zhang, CEO of Cytovance Biologics, Andrew Lees, CEO and Owner at Fina BioSolutions, and Jeffrey Seymour, President and CEO at OKC Innovation District.

Cytovance Biologics, a contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, recently celebrated its 20th anniversary in Oklahoma City. Cytovance marked the milestone with a celebration at Innovation Hall, bringing together representatives from the Greater Oklahoma City Chamber, Life Science Oklahoma, local and government officials, business leaders, and longtime Cytovance partners. “Two decades ago, Cytovance was founded with a vision to create...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters